The Lancet Respiratory Medicine 2021

3 papers
In 2021, *The Lancet Respiratory Medicine* featured research heavily influenced by the global COVID-19 pandemic. Key studies investigated the associations between pre-existing respiratory diseases and the risk of severe COVID-19 outcomes. Other research utilized the WHO Clinical Characterisation Protocol UK to analyze shifts in in-hospital mortality rates during the pandemic's first wave. Prolific authors contributing to these efforts included Julia Hippisley-Cox, Ashley Kieran Clift, and David A. Harrison, whose work provided data on patient risk factors and clinical trends. In addition to pandemic-related research, the journal published work focused on standardizing the management of chronic lung conditions. A notable contribution involved international consensus recommendations for the radiological and clinical diagnosis of bronchiectasis in adults. These criteria were established to provide uniform definitions for use in future clinical trials. Other prominent researchers, such as Ian Pavord and Nicola Lindson, contributed to the year’s discourse on respiratory health. This combination of pandemic response and the refinement of diagnostic standards for chronic diseases characterized the journal's output for the year.

Top Research Directions

The 1 research directions with The Lancet Respiratory Medicine 2021 papers, ranked by paper count, next to 2019. Share is the fraction of the edition’s papers in the direction.

#Direction20212019Share 2021Share 20192019 rank
1Chronic Medication Safety in Acute Viral Infections1033.3%0.0%—

Download all directions as CSV

Institutions

Institutions credited by The Lancet Respiratory Medicine 2021 papers: a paper credits every institution named in its affiliations, once. 6 institutions share 1 credited papers.

#InstitutionPapersShare20192019 rank
100aps1a34 1100.0%0—
2057b2ek35 1100.0%0—
3Oxford University Hospitals NHS Trust 1100.0%0—
4Peking University 1100.0%0—
5University of Nottingham 1100.0%0—
6University of Oxford 1100.0%0—

Download all institutions as CSV

About this data

Papers. The Lancet Respiratory Medicine 2021 lists 3 papers on Lacuna, duplicate versions counted once; rejected and withdrawn submissions are left out.

Directions. Directions are Lacuna’s clustering of the concept elements extracted from each paper, so a paper can belong to several and direction counts add up to more than the paper count. A direction’s share is its papers divided by the edition’s papers. Comparisons with 2019 use shares, since the edition went from 5 to 3 papers.

Institutions. A paper credits each institution named in its affiliations, resolved to a ROR record, once. 1 of 3 papers (33.3%) credit at least one institution and are the base for institution shares; the rest have no resolved affiliation yet.

Data. Counts come from Lacuna’s data build of 2026-11-19 and change as papers are added. Tables as CSV: directions · institutions. Cite as: Lacuna, “The Lancet Respiratory Medicine 2021”, https://lacuna.tiptreesystems.com/venue/the-lancet-respiratory-medicine/2021.

Top Authors

AuthorPapers
Karla DiazOrdaz1

Impactful Papers

Papers from The Lancet Respiratory Medicine 2021 that shaped research clusters.

Foundational

Papers

Title
Association between pre-existing respiratory disease and its treatment, and severe COVID-19: a population cohort study
Changes in in-hospital mortality in the first wave of COVID-19: a multicentre prospective observational cohort study using the WHO Clinical Characterisation Protocol UK
Criteria and definitions for the radiological and clinical diagnosis of bronchiectasis in adults for use in clinical trials: international consensus recommendations